ATP6AP1.md
... ...
@@ -21,9 +21,7 @@ timeline
21 21
22 22
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
23 23
24
-|Entity|source |frequency (%)|
25
-|:------:|:-------------:|:-------------:|
26
-|FL |GAMBL genomes|4.85 |
24
+[[include:FL_ATP6AP1.md]]
27 25
28 26
## Mutation pattern and selective pressure estimates
29 27
ATP6V1B2.md
... ...
@@ -21,9 +21,7 @@ timeline
21 21
22 22
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
23 23
24
-|Entity|source |frequency (%)|
25
-|:------:|:-------------:|:-------------:|
26
-|FL |GAMBL genomes|7.39 |
24
+[[include:FL_ATP6V1B2.md]]
27 25
28 26
## Mutation pattern and selective pressure estimates
29 27
CTSS.md
... ...
@@ -22,9 +22,8 @@ timeline
22 22
23 23
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
24 24
25
-|Entity|source |frequency (%)|
26
-|:------:|:-------------:|:-------------:|
27
-|FL |GAMBL genomes|3.93 |
25
+[[include:DLBCL_CTSS.md]]
26
+[[include:FL_CTSS.md]]
28 27
29 28
## Mutation pattern and selective pressure estimates
30 29
MAP2K1.md
... ...
@@ -23,13 +23,8 @@ timeline
23 23
24 24
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
25 25
26
-|Entity|source |frequency (%)|
27
-|:------:|:--------------:|:-------------:|
28
-|DLBCL |GAMBL genomes |1.34 |
29
-|DLBCL |Schmitz cohort|3.19 |
30
-|DLBCL |Reddy cohort |2.20 |
31
-|DLBCL |Chapuy cohort |2.14 |
32
-|FL |GAMBL genomes |1.39 |
26
+[[include:DLBCL_MAP2K1.md]]
27
+[[include:FL_MAP2K1.md]]
33 28
34 29
## Mutation pattern and selective pressure estimates
35 30
VMA21.md
... ...
@@ -21,9 +21,7 @@ timeline
21 21
22 22
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
23 23
24
-|Entity|source |frequency (%)|
25
-|:------:|:-------------:|:-------------:|
26
-|FL |GAMBL genomes|5.08 |
24
+[[include:FL_VMA21.md]]
27 25
28 26
## Mutation pattern and selective pressure estimates
29 27